Pregabalin for the treatment of painful neuropathy

References

• Ziegler D, Gries FA, Spuler M et al. The epidemiology of diabetic neuropathy. J. Diabetes Complicat.6(1), 49–57 (1992).
   PubMedGoogle Scholar
• Calcutt NA. Potential mechanisms of neuropathic pain in diabetes. Int. Rev. Neurobiol.50, 205–228 (2002).
   PubMed Web of Science ®Google Scholar
• Bowsher D. The management of postherpetic neuralgia. Postgrad. Med. J.73(864), 623–629 (1997).
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Schmader KE. Epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Herpes Zoster and Postherpetic Neuralgia. (2nd Edition). Watson CPN, Gershon AA (Eds). Elsevier Press, NY, USA, 39–64 (2001).
   Google Scholar
• Fink K, Dooley DJ, Meder WP et al. Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology42(2), 229–236 (2002).
   PubMed Web of Science ®Google Scholar
• Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J. Pain5(3), 143–149 (2004).
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Strojek L, Greising T et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blind, multicenter, placebo-controlled trial of flexible and fixed dose regimens. Pain115(3), 254–263 (2005).
   PubMed Web of Science ®Google Scholar
• Macdonald RL, Kapur J. Acute cellular alterations in the hippocampus after status epilepticus. Epilepsia40(Suppl. 1), S9–S20 (1999).
   Web of Science ®Google Scholar
• Whitworth TL, Quick MW. Upregulation of gamma-aminobutyric acid transporter expression: role of alkylated γ-aminobutyric acid derivatives. Biochem. Soc. Trans.29(6), 736–741 (2001).
   PubMed Web of Science ®Google Scholar
• Errante LD, Petroff OA. Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure12(5), 300–306 (2003).
   PubMed Web of Science ®Google Scholar
• Dooley DJ, Mieske CA, Borosky SA. Inhibition of K+-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci. Lett.280(2), 107–110 (2000).
   PubMed Web of Science ®Google Scholar
• Lyrica® package insert. Pfizer Inc., New York, NY, USA.
   Google Scholar
• Stahl S. Anticonvulsants and the relief of chronic pain: pregabalin and gabapentin as α(2)δ ligands at voltage-gated calcium channels. J. Clin. Psychiatry65(8), 596–597 (2004).
   PubMed Web of Science ®Google Scholar
• Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain105(1–2), 133–141 (2003).
   PubMed Web of Science ®Google Scholar
• Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia45(Suppl. 6), 13–18 (2004).
   PubMed Web of Science ®Google Scholar
• Huckle R. Pregabalin (Pfizer). Curr. Opin. Investig. Drugs5(1), 82–89 (2004).
   PubMedGoogle Scholar
• Frampton JE, Foster RH. Pregabalin: in the treatment of postherpetic neuralgia. Drugs65(1), 111–118 (2005).
   PubMed Web of Science ®Google Scholar
• Bockbrader HN, Hunt T, Strand JC et al. Pregabalin pharmacokinetics and safety in healthy volunteers: results from two Phase 1 studies. Neurology54(Suppl. 3), A421 (2000).
   PubMed Web of Science ®Google Scholar
• Randinitis EJ, Posvar EL, Alvey CW et al. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J. Clin. Pharmacol.43(3), 277–283 (2003).
   PubMed Web of Science ®Google Scholar
• Rosenstock J, Tuchman M, LaMoreaux L et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain110(3), 624–638 (2004).
   Google Scholar
• Melzak R. The short-form McGill pain questionnaire. Pain30(2), 191–197 (1987).
   PubMed Web of Science ®Google Scholar
• Lesser H, Sharma U, LaMoreaux L et al. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology63(11), 2104–2110 (2004).
   PubMed Web of Science ®Google Scholar
• Richter RW, Portenoy R, Sharma U et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J. Pain6(4), 253–260 (2005).
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Corbin AE, Young JP et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology60(8), 1274–1283 (2003).
   PubMed Web of Science ®Google Scholar
• Sabatowski R, Galvez R, Cherry DA et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomized, placebo-controlled clinical trial. Pain109(1–2), 26–35 (2004).
   PubMed Web of Science ®Google Scholar
• Van Seventer R, Feister HA, Young JP et al. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr. Med. Res. Opin.22(2), 375–384 (2006).
   PubMed Web of Science ®Google Scholar
• Argoff CE, Backonja MM, Belgrade MJ et al. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin. Proc.81(Suppl. 4), S12–S25 (2006).
   Google Scholar
• Argoff CE, Backonja MM, Belgrade MJ et al. Diabetic peripheral neuropathic pain: consensus guidelines for treatment. J. Fam. Pract.55(6), 1–20 (2006).
   PubMedGoogle Scholar
• Gilron I, Bailey JM, Tu D et al. Morphine, gabapentin, or their combination for neuropathic pain. N. Engl. J. Med.352(13), 1324–1334 (2005).
   PubMed Web of Science ®Google Scholar
• Burgoon CF, Bugoon JS, Baldridge GD. The natural history of herpes zoster. JAMA164, 265–269 (1957).
   PubMed Web of Science ®Google Scholar
• Weis O, Swiratanakul K, Weintraub M. Treatment of post herpetic neuralgia and acute herpetic pain with amitriptyline and prophenazine. S. Afr. Med. J.62, 274–275 (1982).
   PubMed Web of Science ®Google Scholar
• Boon R. Efficacy and safety of famciclovir in the treatment of herpes zoster. In: Proceedings of the International Conference on the Varicella Zoster Virus. Paris, France (1995).
   Google Scholar
• Li C, Zhang X, Matthews E et al. Calcium channel α2δ1 subunit mediates spinal hyperexcitability in pain modulation. Pain125(1–2), 20–34 (2006).
   PubMed Web of Science ®Google Scholar
• Li C, Song Y, Higuera E et al. Spinal dorsal horn calcium channel α2δ1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J. Neurosci.24(39), 8494–8499 (2004).
   PubMed Web of Science ®Google Scholar